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LABORATORY AND CLINICAL EVALUATION ON MINOCYCLINE
Tadao KiRiyAMA， Tsuneo KoGANEMARu and Jisaburo SAKAToKu
From the DePartment of Urology， Yamaguchi Cfniversity IMedicaZ School
             （Chairman： Pro／ 」． Sakatoku， M． D．）
   This report deals with the laboratory and clinical． assessment of minocycline on urinary
tract infection．
   The results obtained were surnmarized as follows．
   1） MIC 6f minocycline against 254 strains of bacteria which were isolated from urinary
tract infection during the late four months period in our clinic，一一was determ；ned by plate dilu－
tion rnethod． This determination revealed that StaPhylococcus aureus xvas more sensitive to
minocycline than ahy other bacteria， and that this M工C was not rnore tharl 1．56 mcg／ml in about
three fourths apd was less than O．39 mcg／ml in about a half of these cocci．
   The MIC was less than 12．5rncg／ml in 60．9％ of Staphyloeoecus ePidermidis， in 48．9％ of
Enterococcus， in 46．2％ of Klebsiella， in 58．3％ of E． coZi， in 14．3％ of Cgoaca． lt was impos－
sible to find out Pseudomonas aeruginosa．and Proteus mirabilis having MIC less than 12．5mcg／
mg．
   2） Cross－resistance between minocycline and TC was estimated on ． StaPhyloeoccus， E． coli
and Enterococcus． The cross－resistance was demonstra． ted in the case of StaPhylococcus aureus，
while it was unlikely to be proved in the case of the latter two．
   3） Serum concentration following a peroral administration of 200 mg in two healthy adults
reached a peak level of 1．7 mcg／ml in average four hours later． Urinary recpvery was 6．7％，
for 24．hours．・
   4） Of nineteen patients sut’fering from urinary tract ・infection， eleven were effectively



























Table 1．Susceptibility of bacteria isolated from urinary tract infection to rninocycline
（plate dilution method）
                  MIC （rncg／ml）No． of
st「№奄獅r・川・・．39・．・81．563・136・2512・5255・i1・・≧…
s妙ぬ．翻7θ％3 53 2 11 13 9 7 4 3 3 1
．sオ妙乃・砂昭6γ駕認‘s 23 4 2 1 1 2 1 3 6 21 1
E撹6γooooo錫s 45 4 2 3 2 2 3 6 14
61 3
P∫θ麗4．σθ剛9勿osσ 24 6 18
κz召bs謬θ砺 26 1 3 8 2 1 9 2
E．60あ 48 4 7 9 8 10 4 3 3
P70飽麗漉γαわ漉s 12 1 4 7
α〃。わσo渉θγ 9 2 2 ！ 1． 3
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Fig． 1． Curnulative distribution of suscepti－
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Fig． 2． Cumulative distribution of suscepti－
 bility of E． coli to minocycline （48 strains）
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Fig． 3． Cumulative distribution of suscepti－
 bility of StaPhylocoecus ePidermidis to mino－
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Fig． 4． Cumulative distribution of suscepti－
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Fig． 5． Cumulative distribution of suscepti一











plateauを形成した． StaPhyZococcus ePidermidis 23
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Fig．6， Cross resistance between minocycline
 and TC （staPhylococcus aurezas）
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Fig．’7・： Cross resistanee between minocycline
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Fig． 8． Cross resistance between minocycline
 and TC （En，terococcus）
monas aeruginosa， ProteUS mirabilisには感性なもの
は少なく，これに比べるとCitrobacterには一部に感
性なものが認められた．なおStaPhylococcus aureus














Serum levels and urinary recoveries
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Fig． 9． Serum level and total urinary re－
 covery （peroral adrrrinistration of 200 mg














     血中濃度および尿中回収率













































             桐山・ほか：Minocycline
Table 3． Clinical evaluation of minocycline on infection of urinary tract
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 1    i             I      1            1
16m・1・．…18 af・。， b。u，、n。g，旨卜・
                             ミ        Irt． acute      i17  female  30
18
c…一…5／脇＿i．・；・・
      1；BPH  1
／g male      I68 i lt． acute      i            十3     十3        iPyelonephritis l  I











































































































































  ＊（一） Or一一・2／HPF （÷） 3’一’5／HPF （十1） 6”一10／HPF













（十2） 10一一20／HPF （十3） 20r－50／HPF
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